{"id":4401,"date":"2012-02-28T23:51:36","date_gmt":"2012-02-29T07:51:36","guid":{"rendered":"http:\/\/www.foodanddrugrecall.org\/index.php\/fda-announces-safety-changes-in-labeling-for-some-cholesterol-lowering-drugs\/"},"modified":"2012-02-28T23:51:36","modified_gmt":"2012-02-29T07:51:36","slug":"fda-announces-safety-changes-in-labeling-for-some-cholesterol-lowering-drugs","status":"publish","type":"post","link":"https:\/\/www.foodanddrugrecall.org\/index.php\/fda-announces-safety-changes-in-labeling-for-some-cholesterol-lowering-drugs\/","title":{"rendered":"FDA announces safety changes in labeling for some cholesterol-lowering drugs"},"content":{"rendered":"<p>Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins are being announced today by the U.S. Food and Drug Administration (FDA).<\/p>\n<p>These products, when used with diet and exercise, help to lower a person\u2019s \u201cbad\u201d cholesterol (low-density lipoprotein cholesterol). The products include: Lipitor (atorvastatin), Lescol (fluvastatin), Mevacor (lovastatin), Altoprev (lovastatin extended-release), Livalo (pitavastatin), Pravachol (pravastatin), Crestor (rosuvastatin), and Zocor (simvastatin). Combination products include: Advicor (lovastatin\/niacin extended-release), Simcor (simvastatin\/niacin extended-release), and Vytorin (simvastatin\/ezetimibe).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins are being announced today by the U.S. Food and Drug Administration (FDA). These products, when used with diet and exercise, help to lower a person\u2019s \u201cbad\u201d cholesterol (low-density lipoprotein cholesterol). The products include: Lipitor (atorvastatin), Lescol (fluvastatin), Mevacor (lovastatin), Altoprev &hellip; <a href=\"https:\/\/www.foodanddrugrecall.org\/index.php\/fda-announces-safety-changes-in-labeling-for-some-cholesterol-lowering-drugs\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">FDA announces safety changes in labeling for some cholesterol-lowering drugs<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"1","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,4,3,6],"tags":[],"class_list":["post-4401","post","type-post","status-publish","format-standard","hentry","category-drug-reacalls-safety-notices-information","category-drug-safety-information-podcasts","category-food-drug-recalls","category-food-safety-news"],"_links":{"self":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts\/4401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/comments?post=4401"}],"version-history":[{"count":0,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts\/4401\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/media?parent=4401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/categories?post=4401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/tags?post=4401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}